123 related articles for article (PubMed ID: 38632937)
1. Fluorocarbon Nanodroplets: Their Formation and Stability in Complex Solution Systems.
Ji Y; Zheng J; Geng Z; Wang X; Hou Y; Tian J; Hu J; Zhang Y; Zhang L
Langmuir; 2024 Apr; 40(17):9108-9119. PubMed ID: 38632937
[TBL] [Abstract][Full Text] [Related]
2.
Amir N; Green D; Kent J; Xiang Y; Gorelikov I; Seo M; Blacker M; Janzen N; Czorny S; Valliant JF; Matsuura N
Nucl Med Biol; 2017 Nov; 54():27-33. PubMed ID: 28863330
[TBL] [Abstract][Full Text] [Related]
3. Cavitation characteristics of flowing low and high boiling-point perfluorocarbon phase-shift nanodroplets during focused ultrasound exposures.
Xu T; Cui Z; Li D; Cao F; Xu J; Zong Y; Wang S; Bouakaz A; Wan M; Zhang S
Ultrason Sonochem; 2020 Jul; 65():105060. PubMed ID: 32199255
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Ablation of Prostate Cancer Spheroids Using Acoustically-Activated Nanodroplets.
Aydin O; Vlaisavljevich E; Yuksel Durmaz Y; Xu Z; ElSayed ME
Mol Pharm; 2016 Dec; 13(12):4054-4065. PubMed ID: 27696857
[TBL] [Abstract][Full Text] [Related]
5. Effect of Phase-Change Nanodroplets and Ultrasound on Blood-Brain Barrier Permeability In Vitro.
Vlatakis S; Zhang W; Thomas S; Cressey P; Moldovan AC; Metzger H; Prentice P; Cochran S; Thanou M
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258062
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets.
Abdalkader R; Unga J; Yamashita F; Maruyama K; Hashida M
Biol Pharm Bull; 2019 Dec; 42(12):2038-2044. PubMed ID: 31554747
[TBL] [Abstract][Full Text] [Related]
7. Functional ultrasound-triggered phase-shift perfluorocarbon nanodroplets for cancer therapy.
Guo R; Xu N; Liu Y; Ling G; Yu J; Zhang P
Ultrasound Med Biol; 2021 Aug; 47(8):2064-2079. PubMed ID: 33992473
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic preparation of various perfluorocarbon nanodroplets: Characterization and determination of acoustic droplet vaporization (ADV) threshold.
Melich R; Bussat P; Morici L; Vivien A; Gaud E; Bettinger T; Cherkaoui S
Int J Pharm; 2020 Sep; 587():119651. PubMed ID: 32707242
[TBL] [Abstract][Full Text] [Related]
9. Controllable formation of bulk perfluorohexane nanodroplets by solvent exchange.
Ji Y; Zheng J; Geng Z; Tan T; Hu J; Zhang L; Zhang Y
Soft Matter; 2022 Jan; 18(2):425-433. PubMed ID: 34905593
[TBL] [Abstract][Full Text] [Related]
10. Intracellular growth of nanoscale perfluorocarbon droplets for enhanced ultrasound-induced phase-change conversion.
Martin AL; Seo M; Williams R; Belayneh G; Foster FS; Matsuura N
Ultrasound Med Biol; 2012 Oct; 38(10):1799-810. PubMed ID: 22920544
[TBL] [Abstract][Full Text] [Related]
11. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided chemoradiotherapy of breast cancer using smart methotrexate-loaded perfluorohexane nanodroplets.
Samani RK; Maghsoudinia F; Mehradnia F; Hejazi SH; Saeb M; Sobhani T; Farahbakhsh Z; Mehrgardi MA; Tavakoli MB
Nanomedicine; 2023 Feb; 48():102643. PubMed ID: 36584739
[TBL] [Abstract][Full Text] [Related]
13. Novel method for the formation of monodisperse superheated perfluorocarbon nanodroplets as activatable ultrasound contrast agents.
de Gracia Lux C; Vezeridis AM; Lux J; Armstrong AM; Sirsi SR; Hoyt K; Mattrey RF
RSC Adv; 2017; 7(77):48561-48568. PubMed ID: 29430294
[TBL] [Abstract][Full Text] [Related]
14. Nanodiamonds: A Cutting-Edge Approach to Enhancing Biomedical Therapies and Diagnostics in Biosensing.
Hyder A; Ali A; Buledi JA; Memon AA; Iqbal M; Bangalni TH; Solangi AR; Thebo KH; Akhtar J
Chem Rec; 2024 Apr; 24(4):e202400006. PubMed ID: 38530037
[TBL] [Abstract][Full Text] [Related]
15. Direct incorporation of lipophilic nanoparticles into monodisperse perfluorocarbon nanodroplets via solvent dissolution from microfluidic-generated precursor microdroplets.
Seo M; Matsuura N
Langmuir; 2014 Oct; 30(42):12465-73. PubMed ID: 25188556
[TBL] [Abstract][Full Text] [Related]
16. A Simple and Cost-Effective Method for Producing Stable Surfactant-Coated EGaIn Liquid Metal Nanodroplets.
Xu B; Ye F; Chang G; Li R
Materials (Basel); 2020 Aug; 13(17):. PubMed ID: 32854305
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanodroplets: an emerging trend in gaseous delivery system.
Shende P; Jain S
J Drug Target; 2019 Dec; 27(10):1035-1045. PubMed ID: 30808239
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Ostwald Ripening by Scaffolding Droplets.
Zhang H; Chen S; Zhang B; Zhang X
Langmuir; 2020 Nov; 36(45):13682-13688. PubMed ID: 33143409
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-functionalized gadolinium-loaded phase transition nanodroplets for dual-modal ultrasound/magnetic resonance imaging of hepatocellular carcinoma.
Maghsoudinia F; Tavakoli MB; Samani RK; Hejazi SH; Sobhani T; Mehradnia F; Mehrgardi MA
Talanta; 2021 Jun; 228():122245. PubMed ID: 33773745
[TBL] [Abstract][Full Text] [Related]
20. Physical Characterization to Improve Scalability and Potential of Anesthetic-Loaded Nanodroplets.
Ting SG; Lea-Banks H; Hynynen K
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
